Anthony Economou, DO | |
2865 E Skelly Dr Ste 250, Tulsa, OK 74105-6233 | |
(918) 317-0022 | |
(855) 327-9828 |
Full Name | Anthony Economou |
---|---|
Gender | Male |
Speciality | Ophthalmology |
Experience | 36 Years |
Location | 2865 E Skelly Dr Ste 250, Tulsa, Oklahoma |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1013910090 | NPI | - | NPPES |
100137560A | Medicaid | OK | |
5533545 | Other | OK | AETNA |
1732450 | Other | OK | UNITED HEALTHCARE |
1101708 | Other | OK | FIRST HEALTH |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207W00000X | Ophthalmology | 3145 (Oklahoma) | Secondary |
207WX0009X | Ophthalmology - Glaucoma Specialist | 3145 (Oklahoma) | Primary |
Entity Name | Anthony Economou Do Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1871613547 PECOS PAC ID: 8224137005 Enrollment ID: O20070619000605 |
News Archive
In a new study, researchers found nearly half of those who share explicit images of others without permission feel remorse after the fact and 24% try to deflect blame onto victims.
In the largest analysis of its kind, Duke University Medical Center researchers have found that patients with diabetes who require surgery for ankle fractures have significantly higher rates of complications and higher hospital costs compared to non-diabetic patients.
Preterm infants with respiratory distress syndrome (RDS) face heightened risks of death, critical illness, and prolonged hospitalization, particularly if they progress to develop acute respiratory distress syndrome.
Diabetic patients diagnosed with peripheral neuropathy had lower medical costs and reduced use of anticonvulsant medications when treated with a folate-enriched prescription medical food, according to data presented today at the International Society for Pharmacoeconomics and Outcomes Research 12th Annual European Congress.
Gemin X Pharmaceuticals, a clinical stage biopharmaceutical company developing novel, targeted cancer therapeutics, today announced the completion of patient enrollment in a Phase 2 clinical trial of the Company's lead product candidate obatoclax (GX15-070) for the treatment of extensive-stage small cell lung cancer (SCLC). The trial is designed to evaluate the efficacy and safety of obatoclax, a novel pan Bcl-2 inhibitor, in combination with standard chemotherapy for the first-line treatment of patients with SCLC.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Anthony Economou, DO 2865 E Skelly Dr Ste 250, Tulsa, OK 74105-6233 Ph: (918) 317-0022 | Anthony Economou, DO 2865 E Skelly Dr Ste 250, Tulsa, OK 74105-6233 Ph: (918) 317-0022 |
News Archive
In a new study, researchers found nearly half of those who share explicit images of others without permission feel remorse after the fact and 24% try to deflect blame onto victims.
In the largest analysis of its kind, Duke University Medical Center researchers have found that patients with diabetes who require surgery for ankle fractures have significantly higher rates of complications and higher hospital costs compared to non-diabetic patients.
Preterm infants with respiratory distress syndrome (RDS) face heightened risks of death, critical illness, and prolonged hospitalization, particularly if they progress to develop acute respiratory distress syndrome.
Diabetic patients diagnosed with peripheral neuropathy had lower medical costs and reduced use of anticonvulsant medications when treated with a folate-enriched prescription medical food, according to data presented today at the International Society for Pharmacoeconomics and Outcomes Research 12th Annual European Congress.
Gemin X Pharmaceuticals, a clinical stage biopharmaceutical company developing novel, targeted cancer therapeutics, today announced the completion of patient enrollment in a Phase 2 clinical trial of the Company's lead product candidate obatoclax (GX15-070) for the treatment of extensive-stage small cell lung cancer (SCLC). The trial is designed to evaluate the efficacy and safety of obatoclax, a novel pan Bcl-2 inhibitor, in combination with standard chemotherapy for the first-line treatment of patients with SCLC.
› Verified 3 days ago
Mark Justin Weiss, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1717 S Utica Ave, Ste 107, Tulsa, OK 74104 Phone: 918-742-2428 Fax: 918-742-8435 | |
Dr. Justin Parschauer, D.O. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 6600 S Yale Ave, Suite 800, Tulsa, OK 74136 Phone: 918-491-3900 | |
Dr. Zeb Linston Brister, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 3906 S Peoria Ave, Tulsa, OK 74105 Phone: 918-585-1523 Fax: 918-584-5520 | |
John Thomas Romano, D.O. Ophthalmology Medicare: Medicare Enrolled Practice Location: 4444 S Harvard Ave, Ste 300, Tulsa, OK 74135 Phone: 918-747-2020 Fax: 918-747-2056 | |
Dr. Bruce Ben Pettigrove, M.D. Ophthalmology Medicare: May Accept Medicare Assignments Practice Location: 6606 S. Yale, #220, Tulsa, OK 74136 Phone: 918-492-4122 Fax: 918-492-7451 | |
Shehzad Y Batliwala, D.O Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 10010 E 81st St Ste 100, Tulsa, OK 74133 Phone: 918-250-2020 |